Invaio Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
108
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
10
Invaio General Information
Description
Operator of a multi-platform biotechnology company intended to solve pressing agriculture, nutrition and environmental challenges. The company leverages advanced sciences to understand the physiology of insects and the diverse systems of nature, enabling clients and farmers to reduce pesticide use, conserve water, and improve crop health.
Contact Information
Website
www.invaio.comCorporate Office
- 75 Moulton Street
- Cambridge, MA 02138-1127
- United States
Corporate Office
- 75 Moulton Street
- Cambridge, MA 02138-1127
- United States
Invaio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Accelerator/Incubator | 22-Mar-2022 | Completed | Generating Revenue | |||
| 5. Debt - General | 13-Oct-2021 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 25-May-2021 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2021 | Completed | Startup | |||
| 2. Early Stage VC (Series B) | 05-Feb-2020 | $40M | $62M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 01-Jan-2018 | $22M | $22M | Completed | Startup |
Invaio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-1 | ||||||||
| Series A | 11,298,177 | $0.001000 | $1 | $1 | 1x | $1 | 20.4% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Invaio Comparisons
Industry
Financing
Details
Invaio Competitors (1)
One of Invaio’s competitors is GreenLight Biosciences, a Private Equity-Backed company based in Medford, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GreenLight Biosciences | Private Equity-Backed | Medford, MA |
Invaio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Invaio Patents
Invaio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D1156140-S1 | Tip for use with a delivery assembly, to inject fluids into plants | Active | 31-Jul-2025 | ||
| US-20260223787-A1 | Delivery assemblies and related methods for use in injecting fluids into plants | Pending | 03-Feb-2025 | ||
| WO-2026165282-A1 | Delivery assemblies and related methods for use in injecting fluids into plants | Pending | 03-Feb-2025 | ||
| US-20260041087-A1 | Lipid nanoparticle formulations for agricultural applications | Pending | 08-Aug-2024 | ||
| WO-2026036021-A1 | Lipid nanoparticle formulations for agricultural applications | Pending | 08-Aug-2024 | A01N25/28 |
Invaio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Invaio Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Western Growers Center for Innovation & Technology | Accelerator/Incubator | |||
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Bluwave Capital | Growth/Expansion | Minority | ||
| Charles & Potomac Capital | Family Office | Minority | ||
| Investbridge Capital | Real Estate | Minority |
Invaio Acquisitions (1)
Invaio’s most recent deal was a Merger/Acquisition with Peptyde Bio. The deal was made on 04-Dec-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Peptyde Bio | 04-Dec-2023 | Merger/Acquisition | Agricultural Chemicals |
Invaio FAQs
-
When was Invaio founded?
Invaio was founded in 2018.
-
Where is Invaio headquartered?
Invaio is headquartered in Cambridge, MA.
-
What is the size of Invaio?
Invaio has 108 total employees.
-
What industry is Invaio in?
Invaio’s primary industry is Media and Information Services (B2B).
-
Is Invaio a private or public company?
Invaio is a Private company.
-
What is Invaio’s current revenue?
The current revenue for Invaio is .
-
How much funding has Invaio raised over time?
Invaio has raised $201M.
-
Who are Invaio’s investors?
Western Growers Center for Innovation & Technology, Alexandria Venture Investments, Bluwave Capital, Charles & Potomac Capital, and Investbridge Capital are 5 of 10 investors who have invested in Invaio.
-
Who are Invaio’s competitors?
GreenLight Biosciences is a competitor of Invaio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
